InvestorsHub Logo
Followers 45
Posts 7066
Boards Moderated 0
Alias Born 02/05/2008

Re: shajandr post# 90068

Wednesday, 06/17/2015 5:44:00 AM

Wednesday, June 17, 2015 5:44:00 AM

Post# of 222347
Years ago I remember coming across that company and Ampligen.
I was looking into various orphan drugs... good thing I chose QCOR over this loser.

HEB almost reached $18 at one point! It fell incredibly quickly and looks like the usual pump n dump scam stock.

Chart from 1996-now:
https://www.quandl.com/data/GOOG/AMEX_HEB-Hemispherx-BioPharma-Inc-HEB

I am large shareholder of HEB and an attorney, and I am not afraid to pursue legal recourse against those spreading false information about this company.


Hoo-boy, threats already? RED FLAG!

Hemispherx Biopharma Press Release for
Thursday, June 04, 2015

Hemispherx Biopharma Announces Preliminary Approval of Securities Class Action Settlement

Philadelphia, PA, Thursday, June 04, 2015: Hemispherx Biopharma (NYSE MKT: HEB) announced that the United States District Court for the Eastern District of Pennsylvania has granted preliminary approval of a settlement of the currently pending securities class action, Frater v. Hemispherx Biopharma, Inc. A final settlement hearing has been scheduled for July 22, 2015. The settlement will be paid from the Company’s insurance coverage and will not result in the payment of any funds by the Company. The settlement expressly is not an admission of culpability by Hemispherx or any of the individual defendants.


Ouch! $2.75 million Class Action against HEB?
http://globenewswire.com/news-release/2015/05/18/736833/0/en/Pomerantz-Law-Firm-Announces-Summary-Notice-of-Pendency-and-Proposed-Settlement-of-Hemispherx-Biopharma-Inc-Class-Action-and-Settlement-Hearing-HEB.html

http://www.plainsite.org/dockets/sb6at1vo/pennsylvania-eastern-district-court/frater-v-hemispherx-biopharma-inc-et-al/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.